Matsumoto T, Tostes RC, Webb RC. Uridine adenosine tetraphosphate-induced contraction is increased in renal but not pulmonary arteries from DOCA-salt hypertensive rats. Am J Physiol Heart Circ Physiol 301: H409 -H417, 2011. First published May 6, 2011 doi:10.1152/ajpheart.00084.2011.-Uridine adenosine tetraphosphate (Up 4A) was reported as a novel endothelium-derived contracting factor. Up 4A contains both purine and pyrimidine moieties, which activate purinergic (P2)X and P2Y receptors. However, alterations in the vasoconstrictor responses to Up 4A in hypertensive states remain unclear. The present study examined the effects of Up 4A on contraction of isolated renal arteries (RA) and pulmonary arteries (PA) from DOCA-salt rats using isometric tension recording. RA from DOCAsalt rats exhibited increased contraction to Up 4A versus arteries from control uninephrectomized rats in the absence and presence of N Gnitro-L-arginine (nitric oxide synthase inhibitor). On the other hand, the Up 4A-induced contraction in PA was similar between the two groups. Up 4A-induced contraction was inhibited by suramin (nonselective P2 antagonist) but not by diinosine pentaphosphate pentasodium salt hydrate (Ip 5I; P2X1 antagonist) in RA from both groups. Furthermore, 2-thiouridine 5=-triphosphate tetrasodium salt (2-Thio-UTP; P2Y 2 agonist)-, uridine-5=-(␥-thio)-triphosphate trisodium salt (UTP␥S; P2Y 2/P2Y4 agonist)-, and 5-iodouridine-5=-O-diphosphate trisodium salt (MRS 2693; P2Y 6 agonist)-induced contractions were all increased in RA from DOCA-salt rats. Protein expression of P2Y 2-, P2Y4-, and P2Y6 receptors in RA was similar between the two groups. In DOCA-salt RA, the enhanced Up 4A-induced contraction was reduced by PD98059, an ERK pathway inhibitor, and Up 4A-stimulated ERK activation was increased. These data are the first to indicate that Up 4A-induced contraction is enhanced in RA from DOCA-salt rats. Enhanced P2Y receptor signaling and activation of the ERK pathway together represent a likely mechanism mediating the enhanced Up 4A-induced contraction. Up4A might be of relevance in the pathophysiology of vascular tone regulation and renal dysfunction in arterial hypertension. extracellular nucleotide; ERK; purinoceptor EXTRACELLULAR NUCLEOTIDES contribute to the local regulation of vascular tone and play important roles in pathophysiological processes, including hypertension, diabetes, atherosclerosis, and remodeling (7, 9, 16) . In blood vessels, nucleotides, such as ATP and UTP, can be released from platelets or from adventitial nerves and endothelial cells to induce either vasoconstriction or vasodilation through cell surface purinergic (P2) receptors (1, 8, 15) .
tors are expressed in renal and pulmonary vascular beds (12, 25, 31, 38, 52, 53) , contributing to the physiology of these specialized organ systems (4, 22, 30) . However, the involvement of these purinoceptors on vascular dysfunction associated with arterial hypertension is largely unknown, partially because most of these purinoceptors are capable of mediating responses to several nucleotides, resulting in multiple receptors having overlapping ligand preferences (8, 50) .
The dinucleotide uridine adenosine tetraphosphate (Up 4 A) was identified by Jankowski et al. (35) as a novel potent endothelium-derived contracting factor. Up 4 A is also the first dinucleotide found in living organisms that contains both purine and pyrimidine moieties, which are known to potentially activate both P2X and P2Y receptors. In the last five years since the identification of Up 4 A (35), several reports have indicated that Up 4 A modulates vascular tone in rat aorta (41) , rat pulmonary arteries (23) , mouse renal afferent arterioles (34) , and mouse aorta (24) . Moreover, Jankowski et al. (35) found that in isolated perfused kidney, Up 4 A stimulated vasoconstriction mainly through P2X 1 receptors and probably also through P2Y 2 and P2Y 4 receptors. More recently, findings from this same group indicate that in the rat isolated perfused kidney, in addition to smooth muscle P2X 1 receptor-mediated vasoconstriction, Up 4 A showed dose-dependent P2Y 2 receptor-mediated, long-lasting vasoconstriction (58) . Furthermore, they demonstrated that vasoconstriction by Up 4 A was followed by vasodilation mediated by P2Y 1 and P2Y 2 receptor activation on endothelial cells leading to the release of nitric oxide (NO) (58) . So far, these studies have been carried out only in normal animals, and there is no study to indicate the vascular effects of Up 4 A under pathophysiological conditions, such as arterial hypertension.
There is evidence that Up 4 A might have implications in the pathogenesis of human hypertension (36) . Plasma Up 4 A concentration is increased in human juvenile hypertensives compared with normotensive controls (33) . Up 4 A concentration is significantly correlated with the left ventricular mass in these juvenile hypertensives (33) . However, the vascular responsiveness to Up 4 A in hypertensive subjects remains unexplored/ unknown.
The aim of the present study was to determine whether the vascular effects of Up 4 A are altered in DOCA-salt rats, a salt-dependent experimental model of arterial hypertension (19, 39, 40, 56) . We hypothesized that Up 4 A-induced vasoconstriction is augmented in DOCA-salt hypertension. We used two different arteries [renal artery (RA) because the kidney is unarguably relevant to determination of blood pressure and extralobar pulmonary artery (PA), which is an important artery to determinate capacitance of pulmonary circulation (57) ]. To test our hypothesis and to identify the mechanisms involved in Up 4 A-altered vasoconstriction, we performed functional studies on RA and PA from normotensive and DOCA-salt rats.
MATERIALS AND METHODS
Reagents. ACh, DOCA, phenylephrine (PE), diinosine pentaphosphate pentasodium salt hydrate (Ip 5I), suramin, and antibodies against ␤-actin, P2Y 2, and P2Y4 were all purchased from Sigma Chemical (St. Louis, MO). The antibody against P2Y 6 was obtained from Enzo Life Sciences (Plymouth Meeting, PA), whereas antibodies against ERK1/2 and phosphorylated ERK1/2 (pT202/pY204) were obtained from Cell Signaling Technology (Danvers, MA). PD98059 and N Gnitro-L-arginine (L-NNA) were obtained from Calbiochem (San Diego, CA). Up4A was obtained from Biolog Life Science Institute (Bremen, Germany). 2-Thiouridine 5=-triphosphate tetrasodium salt (2-ThioUTP), uridine-5=-(␥-thio)-triphosphate trisodium salt (UTP␥S), and 5-iodouridine-5=-O-diphosphate trisodium salt (MRS 2693) were obtained from Tocris Bioscience (Ellisville, MO). Drugs were dissolved in sterile HPLC grade water. Horseradish peroxidase-linked secondary antimouse and anti-rabbit antibodies were purchased from GE Healthcare (Piscataway, NJ).
Animals. Male Wistar rats (8 wk old, 230 -250 g; Harlan Laboratories, Indianapolis, IN) were used in this study. All procedures were performed in accordance with the Guiding Principles in the Care and Use of Animals and approved by the Medical College of Georgia Committee on the Use of Animals in Research and Education. The animals were housed three per cage on a 12-h:12-h light/dark cycle and fed a standard chow diet with water ad libitum.
DOCA-salt hypertension, systolic blood pressure measurements, and assessment of left ventricular hypertrophy. DOCA-salt hypertension was induced in rats as previously described (19, 39, 40) . Briefly, all animals were uninephrectomized under anesthesia and were given no further treatment (Uni rats) or received 1% NaCl plus 0.2% KCl in the drinking water and DOCA silastic pellets (0.2 g/kg), which were implanted subcutaneously in the scapular region (DOCA-salt rats). The duration of treatment was 4 to 5 wk.
One week before euthanasia, systolic blood pressure (SBP) was measured by the tail-cuff method using a CODA system (Kent Scientific). At the end of 4 to 5 wk of treatment, RA and PA arteries were removed and they were submitted to experimental procedures.
Left-ventricular hypertrophy was assessed by left-to-right ventricular ratio and left ventricular body weight index after removing the atria and the right ventricle free wall and separating them from the left ventricle, including the septum.
Arterial isolation and functional studies. Vascular isometric force was recorded by myograph technique as previously described (19, 20, 27, 39, 40) . After euthanasia, the left and right PA and the main branch of the RA were isolated and placed in an ice-cold physiological salt solution (PSS). This solution consisted of (in mM) 130.0 NaCl, 4.7 KCl, 14.9 NaHCO3, 5.5 dextrose, 1.18 KH2PO4, 1.17 MgSO47H2O, 1.6 CaCl22H2O, and 0.026 EDTA. The artery was carefully cleaned of all fat and connective tissue under a stereomicroscope. The arteries were then cut into 2-mm rings (2-4 rings were obtained from each animal) and mounted on a wire myograph (Danish MyoTech; Aarhus, Denmark) filled with 5 ml PSS and continuously gassed with 95% O2-5% CO2 while maintaining temperature at 37°C. The rings were stretched until an optimal resting tension of 10 mN (PA) or 3 mN (RA) and then allowed to equilibrate for at least 45 min. The optimal basal tensions were established from preliminary lengthactive tension curves, and these were similar in arteries from DOCAsalt and Uni groups (data not shown). Arterial integrity was assessed by contracting the segments with a depolarizing concentration of potassium chloride (KCl; 120 mM) and subsequently with phenylephrine (PE; 10 Ϫ5 M) followed by relaxation with ACh (10 Ϫ5 M). (19, 20, 43) ].
Western blotting. The protein levels of P2Y 2, P2Y4, and P2Y6 receptors and of phosphorylated ERK1/2 and total ERK1/2 were quantified using immunoblotting procedures, essentially as described before (19, 20, 39, 40) . RA from DOCA-salt and Uni rats were isolated, cleaned from fat, dissected, and frozen in liquid nitrogen. To investigate the expression of phospho-ERK1/2 in RA upon Up 4A stimulation, the RA rings were incubated with 10 Ϫ4 M L-NNA or with 10 Ϫ4 M L-NNA plus 10 Ϫ5 M PD98059 for 30 min. After incubation, the rings were exposed to 3 ϫ 10 Ϫ6 M Up4A for 5 min. These rings were removed rapidly and rinsed with ice-cold Ca 2ϩ -free PSS containing 1 mM sodium orthovanadate and frozen in liquid nitrogen. Proteins (20 g for P2Y receptor or 10 g for phospho-ERK1/2 and total ERK1/2) extracted from the arteries were separated by electrophoresis on a 10% polyacrylamide gel and transferred to a nitrocellulose membrane. Nonspecific binding sites were blocked with 5% skim milk in Tris-buffered saline solution with Tween (0.1%) for 1 h at 24°C. Membranes were then incubated with antibodies overnight at 4°C. Antibodies were as follows: anti-P2Y 2 (42 kDa; 1:200), anti-P2Y 4 (78 kDa; 1:500), anti-P2Y6 (100 kDa; 1:500), anti-phospho-ERK1/2 (pT202/pY204; 44 and 42 kDa; 1:1,000), anti-ERK1/2 (44 and 42 kDa; 1:1,000), and ␤-actin (42 kDa; 1:15,000). After incubation with secondary antibodies, signals were revealed with chemiluminesence, visualized by autoradiography, and quantified densitometrically. Results were normalized by ␤-actin expression and expressed as a percentage of control.
Data analyses and statistics. Arterial contractions recorded from the myograph were expressed as changes in the displacement from baseline in millinewtons and were represented as percent maximum contraction to 120 mM KCl (percent contraction). The contractions induced by 120 mM KCl were similar between DOCA-salt and Uni groups in RA [12. 80 Ϯ 0.96 mN (n ϭ 57) and 15.03 Ϯ 0.88 mN (P Ͼ 0.05; n ϭ 54), respectively] and PA [9.31 Ϯ 0.75 mN (n ϭ 18) and 8.86 Ϯ 0.36 mN (P Ͼ 0.05; n ϭ 18), respectively]. Agonist concentration-response curves were fitted using a nonlinear interactive fitting program (Graph Pad Prism 5.0; GraphPad Software, San Diego, CA). Data are expressed as means Ϯ SE. Statistical analysis of the concentration-response curves was performed by using two-way ANOVA for comparison between the groups. When compared with the control Uni group, data were analyzed using ANOVA with post hoc Bonferroni testing or Student's t-test. Western blot data were analyzed by one-sample t-test or ANOVA with post hoc Bonferroni testing. The values of P Ͻ 0.05 were considered statistically significant.
RESULTS
SBP and body weight of the rats. At 3 or 4 wk, DOCA-salt rats displayed higher SBP (in mmHg), compared with Uni rats (186 Ϯ 4, n ϭ 35 vs. 134 Ϯ 2, n ϭ 35, P Ͻ 0.001, respectively). At the time of the experiment, the body weight of the DOCA-salt rats was lower than that of Uni rats (351.1 Ϯ 6.2 g, n ϭ 35 vs. 428.1 Ϯ 5.2 g, n ϭ 3, P Ͻ 0.001, respectively).
To evaluate left ventricular hypertrophy, we measured left ventricle-to-body weight ratio and left-to-right ventricular ratio, which are important indexes of left ventricular hypertrophy (13, 32) . These parameters of the DOCA-salt rats were significantly higher than that of Uni rats (left ventricle-to-body weight ratio, 2.77 Ϯ 0.05 mg/g, n ϭ 35 vs. 1.83 Ϯ 0.02 mg/g, n ϭ 35, P Ͻ 0.001, respectively; left-to-right ventricular ratio, 4.48 Ϯ 0.12, n ϭ 35 vs. 3.45 Ϯ 0.08, n ϭ 35, P Ͻ 0.001, respectively).
Up 4 A and PE reactivity in RA and PA. Cumulative administration of Up 4 A (10 Ϫ9 Ϫ 3 ϫ 10 Ϫ5 M)-induced concentration-dependent contractions in RA (Fig. 1A) and PA (Fig. 1B) rings from both DOCA-salt and Uni rats. The Up 4 A-induced concentration-dependent contractile response was significantly greater in RA rings from DOCA-salt rats than in those from Uni rats (Fig. 1A) . On the other hand, in the PA rings, the Up 4 A-induced contraction was similar between DOCA-salt and Uni rats (Fig. 1B) . Exposure of RA (Fig. 1C) (43) (44) (45) (46) . Indeed, Up 4 A-induced NO-dependent relaxation has been observed in rat aorta (41) and in rat perfused kidney (58) . To mask any putative NO component in Up 4 A-induced contraction in the RA and PA, we used a representative NOS inhibitor. In the presence of L-NNA (10 Ϫ4 M), which inhibits both basal and agonist-induced NOS activity, Up 4 A-induced contraction was increased in RA and PA from both the DOCA-salt and Uni groups ( Fig. 1 vs. Fig. 2 ). In the presence of L-NNA, Up 4 Ainduced contraction was significantly greater in RA rings from DOCA-salt than in those from Uni ( Fig. 2A) but was similar in PA rings between DOCA-salt and Uni (Fig. 2B) . ( Fig. 2C) . On the other hand, pretreatment with a P2X 1 receptor antagonist Ip 5 I (10 Ϫ4 M) did not affect Up 4 A-induced contraction either in DOCA-salt or Uni rats (Fig. 2D) .
Effects of P2 receptor antagonism on Up
Selective P2Y receptor agonist-induced contraction in RA. To investigate the possible mechanisms underlying the alterations in Up 4 A-mediated responses in RA from DOCA-salt rats, we next examined the effects of selective P2Y receptor agonists in the presence of 10 Ϫ4 M L-NNA. Interestingly, 2-Thio-UTP [P2Y 2 selective agonist (Fig. 3A) ]-, UTP␥S [P2Y 2 /P2Y 4 selective agonist (Fig. 3B) ]-, and MRS 2693 [P2Y 6 selective agonist (Fig. 3C) ]-induced contractions were all significantly increased in RA from DOCA-salt rats versus Uni rats.
Protein expression of P2Y receptors in RA. Conceivably, an increased expression of P2Y receptors in RA could underlie the enhanced Up 4 A vasoconstriction observed in DOCA-salt rats. Accordingly, we examined the protein expression of P2Y receptors in RA by immunoblotting (Fig. 4) . Expression levels of P2Y 2 (Fig. 4A ) and P2Y 4 (Fig. 4B) receptors were similar between arteries from DOCA-salt and Uni rats. The vascular expression of P2Y 6 receptor tended to be higher in DOCA-salt than in Uni rats; however, statistical significance was not reached (P ϭ 0.23; Fig. 4C) .
Effect of ERK pathway inhibition on Up 4 A-induced contraction in RA.
The ERK pathway plays important roles in the regulation of vascular tone (19, 20, 43) . Pretreatment of RA with an ERK inhibitor (PD98059; 10 Ϫ5 M) markedly reduced Up 4 A-induced contractions in the presence of L-NNA (10 Ϫ4 M) in both DOCA-salt and Uni rats (Fig. 5) .
Effect of Up 4 A on ERK activation in RA.
Collectively, the present data (Fig. 5 ) and previous reports (19, 20, 43) suggest that the ERK pathway modulates contractile responses of vascular smooth muscle. As shown in Fig. 6 , Up 4 A (3 ϫ 10 Ϫ6 M)-stimulated ERK1/2 phosphorylation (activation), as detected by means of Western blotting, was significantly greater in RA from DOCA-salt rats than in those from Uni rats. The phosphorylated ERK1/2 level was greatly suppressed by PD98059 (10 Ϫ5 M) treatment. The total ERK1/2 expression was similar among these groups (Fig. 6C ).
DISCUSSION
The main conclusion to be drawn from the present study is that enhanced Up 4 A-induced contraction in RA, but not in PA, of DOCA-salt hypertensive rats is due to increased activation of P2Y receptor signaling, and the mechanisms underlying this enhancement may be related to increases in ERK1/2 activity.
Up 4 A is the first dinucleotide containing one purine and one pyrimidine moiety found in living organisms (35) . Although Up 4 A has been characterized as a potent constrictor in rat aorta (41) , rat pulmonary arteries (23), rat perfused kidney (35, 58) , mouse aorta (24) , and mouse renal afferent arterioles (34) , there are no studies on its vascular effects in vessels from animals with vascular disease. The present study is the first to show enhancement of Up 4 A-induced contraction in RA in a salt-dependent model of hypertension, the DOCA-salt rats.
In general, NO negatively modulates vasoconstrictor responses in smooth muscle (4, 43, 44) . Indeed, Up 4 A-induced NO-dependent relaxation has been observed in rat aorta (41) and in rat perfused kidney (58) . Moreover, Up 4 A-induced contraction is increased by treatment with NOS inhibitor in PA (23) and in perfused kidney (34, 58) . In the present study, we found that Up 4 A-induced contraction was augmented in the presence of a NOS inhibitor in both the DOCA-salt and Uni groups. However, it should be noted that under such condition, of masking NO component, Up 4 A-induced contraction was still greater in RA from DOCA-salt rats versus Uni group. These results suggest that the hyperreactivity to Up 4 A in RA from DOCA-salt rats may be attributable to alterations on smooth muscle signaling rather than a defect in NO activity/ signaling upon Up 4 A stimulation.
The purine and pyrimidine moieties of Up 4 A potentially activate P2X and P2Y receptors (35, 36) . Several reports suggest that upregulation of P2 receptors is associated with the development of cardiovascular diseases (10, 29, 55) . The activation of both P2X and P2Y receptors on smooth muscle cells leads to vasoconstriction in several arteries (9, 16, 30) . Gui et al. (23) suggested that Up 4 A leads to contraction of rat isolated PA probably via both suramin-sensitive and suraminresistant P2Y receptors. In rat perfused kidney, Up 4 A-induced vasoconstriction depends not only on the activation of the P2X 1 receptor (35) but also on the activation of the P2Y 2 receptor (58). In the present study, the increased Up 4 A-induced contraction in RA from DOCA-salt rats was not due to the Fig. 4 . The receptor expressions of P2Y2, P2Y4, and P2Y6 are similar between RA from DOCA-salt and Uni rats. Analysis of P2Y2 (A), P2Y4 (B), and P2Y6 (C) protein expression in RA obtained from DOCA-salt and Uni rats is shown. Left: representative Western blots for P2Y2, P2Y4, P2Y6, and ␤-actin. Proteins were subjected to 10% SDS-PAGE and then transferred to nitrocellulose membranes. They were then incubated with a primary antibody specific for P2Y2 (42 kDa), P2Y4 (78 kDa), P2Y6 (100 kDa), or ␤-actin (42 kDa) and also with a secondary anti-rabbit or anti-mouse antibody. Right: bands were quantified as described in MATERIALS AND METHODS. Ratios were calculated for the optical density of each receptor over that of ␤-actin. Data are means Ϯ SE from 4 experiments. (17). P2Y 2 and P2Y 6 receptors appear to be the most abundant. P2Y 1 receptor expression is very low or undetectable in contractile vascular smooth muscle cells (17, 49) . All P2Y receptor subtypes are coupled to phospholipase C activation and cause an elevation in the intracellular Ca 2ϩ concentration (21, 49) . Moreover, using P2Y 6 receptor knockout mice, Bar et al. (3) demonstrated that the P2Y 6 receptor is responsible for the contractile action of both UDP and UTP and that P2Y 6 receptor is expressed and functional in vascular smooth muscle cells. In the present study, we found that in isolated RA: 1) Up 4 A-induced contraction is inhibited (but not abolished) by suramin, which contrasts with the findings that P2Y 6 receptor is usually insensitive to suramin (11, 51) ; 2) increased contractions are induced by the selective agonists for P2Y 2 , P2Y 2 /P2Y 4 , or P2Y 6 in DOCA-salt rats; and 3) these arteries express P2Y 2 -, P2Y 4 -, and P2Y 6 receptors; however, these expressions did not change between two groups. Taken together, the evidence and our results indicate that the increased Up 4 A-induced contraction in RA from DOCA-salt rats is due to activation of P2Y receptors and activation of downstream component(s) of P2Y receptor. However, the possibility of P2Y 6 receptor activation contributing to augmented Up 4 A-induced contraction in RA from DOCA-salt rats cannot be completely ruled out considering that suraminresistant contraction induced by Up 4 A is higher in DOCA-salt rats; P2Y 6 agonist-induced contraction was very weak, but specifically unmasked in DOCA-salt rats; and P2Y 6 receptor expression was slightly increased in DOCA-salt rats. However, further studies will be required to determine how and to what extent abnormal/augmented activation of P2Y receptors are involved in the increased Up 4 A-induced vasoconstriction in this hypertensive model. Currently, it is not possible to study single P2Y receptor subtypes due to the lack of selective antagonists.
Various signal transduction pathways (which are associated with vasoconstriction) activated by P2Y receptor stimulation have been proposed, including MAPK, Rho A/Rho kinase, and EGF receptor (EGFR) transactivation (47, 54) . Moreover, several reports have demonstrated that these signal transduction pathways are altered in various animal models, including mineralocorticoid hypertension (5, 18, 19, 59) . In the present study, we observed that Up 4 A-induced contraction was mark- edly suppressed by ERK inhibition. Furthermore, Up 4 A-stimulated ERK activation was greater in RA from DOCA-salt rats than in those from Uni rats. These results strongly indicate that the ERK pathway makes a substantial contribution to the differences in Up 4 A-induced contraction observed between DOCA-salt and Uni rats. However, other signaling pathway(s) may also contribute to the enhanced Up 4 A-induced contraction because the difference in RA Up 4 A-induced contraction between two groups could not be completely abolished by treatment with ERK inhibitor. Therefore, future research will need to focus on the changes in signal transduction pathways activated by Up 4 A in animals in a hypertensive state.
Up 4 A has been proposed as a circulating, endotheliumderived vasoconstrictor since it is released from human endothelial cells stimulated by agonists such as ACh and endothelin-1 (ET-1) or by mechanical stress. Furthermore, these stimulated levels of Up 4 A are sufficient to produce vasoconstriction and increase mean arterial blood pressure (35) . In previous reports, the circulating level of Up 4 A is in the nanomolar range (33, 35) , and such lower concentrations of Up 4 A can lead to vasoconstriction in perfused systems (34, 35, 58) . Considering a report that suggested the circulating Up 4 A level is correlated with the left ventricular mass (33) and that DOCA-salt rats exhibit left ventricular hypertrophy, it is possible that the circulating Up 4 A level is increased in DOCA-salt hypertensive rats. With the use of the myograph technique, higher concentrations of Up 4 A (i.e., in the micromolar range) were required to achieve adequate vasoconstriction (even though Up 4 A sensitivity is increased in RA rings from DOCA-salt rats), and this is consistent with previous reports using other arterial rings in the myograph system (23, 24, 41) . The discrepancy between these studies may be explained by differences between these methodologies. Although previous studies reported that the circulating Up 4 A level is in nanomolar range (33, 35) , the local level of Up 4 A may transiently reach higher concentrations (i.e., over the nanomolar range) leading to vasoconstriction. Endothelial cell activation and release of Up 4 A from the endothelium (or unknown sources) may be different in various regions and conditions. However, future experiments need to be performed to address this question.
In our DOCA-salt model, the hyperreactivity to Up 4 A was specifically seen in RA but not in PA. This suggests that Up 4 A may be important for the regulation of systemic vascular tone and have a functional role in the regulation of renal and pulmonary blood flow in hypertensive states. There are several reports suggesting that the basal renal perfusion pressure does not differ between DOCA-salt rats and controls. However, the responsiveness to various drugs (e.g., ET-1, ACh) on renal perfusion pressure is altered in DOCA-salt hypertensive rats (26, 28) . On the other hand, the PA is expected to be less affected by hypertension, since the blood pressure in this artery is known to be much lower than the blood pressure in systemic arteries (2, 6) . Moreover, in small mesenteric arteries, which are important resistance vessels (27) , Up 4 A-induced contraction was smaller in DOCA-salt rats than in Uni rats (unpublished observation). All together, these data suggest that the Up 4 A-mediated contraction may be heterogenous among various vascular beds in systemic hypertension. However, to establish our hypothesis, future studies are needed to investigate the vasoconstrictor effects of Up 4 A in various arteries.
In conclusion, the present findings indicate that increased activation of P2Y receptors and ERK1/2 pathway represents a likely mechanism mediating the enhancement of Up 4 A responses in DOCA-salt hypertensive rats. Because it was shown in young hypertensive patients that the Up 4 A concentration correlates with blood pressure (33) , results of the present study indicate that abnormal vascular responsiveness to Up 4 A may contribute to the development of arterial hypertension and/or aggravate renal dysfunction associated with hypertension. Understanding the signal transduction and regulation of vascular tone by Up 4 A may be of extreme value to understanding the pathophysiology and treatment of hypertension.
GRANTS
This study was supported in part by the National Institutes of Health (Grants R01 HL-071138 and R01 DK-083685) and by the Naito Foundation Japan.
DISCLOSURES
No conflicts of interest, financial or otherwise, are declared by the author(s).
